Jenny Gunnergren Selected Research

mesdopetam

1/2020

Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jenny Gunnergren Research Topics

Disease

1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Dyskinesias (Dyskinesia) 01/2020

Drug/Important Bio-Agent (IBA)

1	mesdopetamIBA 01/2020
1	AminesIBA 01/2020
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2020